← Back to Clinical Trials
Recruiting NCT05609474

NCT05609474 Trajectories and Reactions of Users and Relatives Consulting French Youth Addiction Services

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05609474
Status Recruiting
Phase
Sponsor Hôpital le Vinatier
Condition Addiction
Study Type OBSERVATIONAL
Enrollment 1,430 participants
Start Date 2023-02-15
Primary Completion 2027-02-15

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 25 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,430 participants in total. It began in 2023-02-15 with a primary completion date of 2027-02-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In France, the "Consultations Jeunes Consommateurs" (CJC) are the services specialized in the reception of young people for addiction problems. There are more than 500 CJCs throughout France. Depending on the situation, the CJC develops an early intervention strategy aimed either at reducing the risk of developing an addiction or at accelerating entry into appropriate care. The CJCs also meet with family members or professionals who may also independently request help or advice. Set up by the State since 2004, the action of the CJCs has never been formally evaluated. Only descriptive studies, carried out by the French Observatory of Drugs and Drug Addiction (OFDT), have made it possible to better understand the profile of people who consult CJCs. However, no longitudinal study has yet been carried out to understand the factors associated with the overall evolution of users consulting CJCs, nor with the level of satisfaction of users and those around them. Such objectives are complex, due to the diversity of situations encountered in CJCs and the heterogeneity of the CJCs themselves.

Eligibility Criteria

Inclusion Criteria: For users : * First consultation in CJC * From 12 to 25 years old For caregivers : * First consultation in CJC (with or without the youth) or second consultation if accompanying a user * ≥ 18 ans Exclusion Criteria: * inability to reach by phone * Insufficient french level

Contact & Investigator

Central Contact

LOUIS FERDINAND LESPINE

✉ louis-ferdinand.lespine@ch-le-vinatier.fr

📞 0033437913461

Principal Investigator

Benjamin ROLLAND, PhD

PRINCIPAL INVESTIGATOR

Centre Hospitalier le Vinatier

Frequently Asked Questions

Who can join the NCT05609474 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 25 Years, studying Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05609474 currently recruiting?

Yes, NCT05609474 is actively recruiting participants. Contact the research team at louis-ferdinand.lespine@ch-le-vinatier.fr for enrollment information.

Where is the NCT05609474 trial being conducted?

This trial is being conducted at Bron, France.

Who is sponsoring the NCT05609474 clinical trial?

NCT05609474 is sponsored by Hôpital le Vinatier. The principal investigator is Benjamin ROLLAND, PhD at Centre Hospitalier le Vinatier. The trial plans to enroll 1,430 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology